Biotech
The Startups Racing to Outsmart the Superbug Crisis
As antibiotic resistance accelerates into a global emergency, a bold generation of biotech startups is rewriting the rules of infectious disease.
As antibiotic resistance accelerates into a global emergency, a bold generation of biotech startups is rewriting the rules of infectious disease.
Synthetic biology is rewriting the rules of evolution — and the implications for medicine, industry, and humanity are staggering.